Novacyt (XPAR:ALNOV) COGS-to-Revenue : 0.50 (As of Jun. 2023)

View and export this data going back to 2012. Start your Free Trial

What is Novacyt COGS-to-Revenue?

Novacyt's Cost of Goods Sold for the six months ended in Jun. 2023 was €1.95 Mil. Its Revenue for the six months ended in Jun. 2023 was €3.89 Mil.

Novacyt's COGS to Revenue for the six months ended in Jun. 2023 was 0.50.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Novacyt's Gross Margin % for the six months ended in Jun. 2023 was 49.86%.

Novacyt COGS-to-Revenue Historical Data

The historical data trend for Novacyt's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Novacyt COGS-to-Revenue Chart

Novacyt Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

COGS-to-Revenue

Get a 7-Day Free Trial

0.39

0.24

0.70

0.73

Novacyt Semi-Annual Data
	Dec13	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23
COGS-to-Revenue	Get a 7-Day Free Trial															0.98	0.33	0.76	0.62	0.50

Novacyt COGS-to-Revenue Calculation

Novacyt's COGS to Revenue for the fiscal year that ended in Dec. 2022 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	17.585	/	24.192
	=	0.73

Novacyt's COGS to Revenue for the quarter that ended in Jun. 2023 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	1.951	/	3.891
	=	0.50

Novacyt (XPAR:ALNOV) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Novacyt's Gross Margin % for the six months ended in Jun. 2023 is calculated as:

Gross Margin %	=	1	-	COGS to Revenue
	=	1	-	Cost of Goods Sold / Revenue
	=	1	-	1.951 / 3.891
	=	49.86 %

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

Novacyt COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Novacyt's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Novacyt (XPAR:ALNOV) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Novacyt SA (XPAR:ALNOV) » Definitions » COGS-to-Revenue

Comparable Companies

Traded in Other Exchanges

NVYTF:USA NCYT:UK NYZ:Germany

Address

13, Avenue Morane Saulnier, Velizy-Villacoublay, FRA, 78140

Website

https://www.novacyt.com

Novacyt SA is engaged in developing and selling diagnostic products for cancer and infectious diseases. The company operates its business through the following business segments. Primerdesign is the designer, manufacturer, and marketer of molecular 'real-time' qPCR testing devices and reagents in the areas of infectious diseases based in Southampton, UK: IT-IS International segment develops PCR devices for the life sciences and food testing industry and Corporate segment.

Novacyt (XPAR:ALNOV) Headlines

No Headlines